Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Peer Review reports

Original Submission
29 Nov 2013	Submitted	Original manuscript
30 Apr 2014	Reviewed	Reviewer Report - Massimo Di Maio
30 Jun 2014	Reviewed	Reviewer Report - Michael von Bergwelt-Baildon
10 Jul 2014	Reviewed	Reviewer Report - Oliver Riesterer
14 Aug 2014	Author responded	Author comments - Alfred Zippelius
Resubmission - Version 2
14 Aug 2014	Submitted	Manuscript version 2
1 Sep 2014	Reviewed	Reviewer Report - Massimo Di Maio
4 Sep 2014	Reviewed	Reviewer Report - Michael von Bergwelt-Baildon
7 Sep 2014	Reviewed	Reviewer Report - Oliver Riesterer
16 Sep 2014	Author responded	Author comments - Alfred Zippelius
Resubmission - Version 3
16 Sep 2014	Submitted	Manuscript version 3
Publishing
25 Sep 2014	Editorially accepted
6 Oct 2014	Article published	10.1186/1471-2407-14-748

Back to article page